Progressive Democrats want to wrestle “Medicare for all” into their party's platform. But strategists, industry and the results of recent primaries say the country isn't ready for it yet.
The Justice Department and U.S. Drug Enforcement Administration proposed to reduce manufacturing quotas for the six most frequently abused opioids by 10% in 2019 amid the historic epidemic.
The Trump administration reportedly is nearing completion of a new immigration rule that healthcare providers and plans fear will harm public health and their ability to serve millions of low-income children and families.
In an effort to encourage ACOs to take on downside risk earlier, it plans to end the Track 1 upside-risk-only model.
The individual market is stable but expensive. As the government bears more of the cost, some industry and policy analysts question its long-term role in expanding coverage.
A major player in 340B drug discount reforms, Rep. Chris Collins (R-N.Y.) can't serve on the House Energy & Commerce Committee, a key health committee, until federal charges of insider trading are resolved.
HHS announced it will maintain Title X family planning funding for all current grantees as well as 12 new program entrants amid Planned Parenthood's pending lawsuit over the Trump administration's new grant criteria.
Hoping to leverage election-year politics, Senate Democrats will introduce legislation to upend the Trump administration's expansion of short-term insurance plans.
The bill would expand health coverage to all New Yorkers, including undocumented immigrants, and would not require copays or deductibles. The measure has passed the Assembly in each of the past four years, but it hasn't advanced in the Republican-controlled Senate.
HHS will lower premiums for Medicare prescription drug plans next year, and the agency credited lower drug prices for the change.
A key Senate health panel explored ways to standardize prior authorization across the insurance industry, but at least one witness was frustrated that lawmakers focused on creating new regulations before rolling back existing rules.
The governors of Washington, Hawaii, Oregon and New York say they will reject federal family planning funds if the Trump administration's proposed changes go into effect.